Skip to main content
. 2018 Mar 3;23:176–181. doi: 10.1016/j.rmcr.2018.03.003

Table 1.

Literature Review of the case reports of PTCL-NOS with endobronchial lesion.

Age (years old)/Gender CT Findings Stage Treatment Outcome
81/M4)
  • Mass inside the bronchus intermedius

  • Right-sided chronic pyothorax with calcified foci

I E
  • One course of THP-COP therapy

  • Fenestration surgery for the right-sided chronic pyothorax

  • No recurrence for 1 year after treatment.

51/M5)
  • Right lower lobe infiltration

IV
  • Chemotherapy (Details unknown)

  • Chemotherapy was effective (Details of the subsequent process is unknown).

68/M (This case)
  • Right axillary lymphadenopathy

  • Right hilar mass with obstruction of the main bronchus

IV
  • Six courses of CHOP therapy and three courses of CHASE therapy

  • CHOP therapy was effective, but the disease relapsed after the 6th course.

  • The patient finally died due to septic shock after the 3rd course of CHASE therapy.

  • He survived for 8 months after diagnosis.

THP-COP therapy: pirarubicin, cyclophosphamide, vincristine, and prednisone.

CHOP therapy: cyclophosphamide, adriamycin, vincristine, and prednisolone.

CHASE therapy: cyclophosphamide, cytarabine, etoposide, and dexamethasone.